Clinical Trial Update: Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

View source ↗

Summary

Clinical trial update on anti-IGF-1R antibodies for Graves' disease and Graves' ophthalmopathy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Thyroiditis
• Graves Disease
• Graves Ophthalmopathy

Drugs mentioned

• Anti-IGF-1R antibodies

Snippet

Sponsor: University of Pisa | Conditions: Graves Ophthalmopathy, Graves Disease | Status: COMPLETED